Evogene Ltd. (Nasdaq/TASE: EVGN) ("Evogene"), a pioneering computational chemistry company specializing in generative design of small molecules for the pharmaceutical and agricultural industries, and ...

Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and ...

Researching are throwing lots of ideas at the wall to see what sticks, but the U.S. just put some serious cash behind the idea of 3D bioprinting.

The government has proposed new rules for the nation's transplant system that aim to increase use of certain donated organs ...

MCS-8 is developed using Jyong Biotech’s core patented pharmaceutical composition technology, which Company believes significantly enhances bioavailability and improves physiological efficacy, ...

Government to invest £2bn in NHS cancer services in England as figures show diagnosis made every 75 seconds in the UK ...

Unlike virtually every other cell in the human body, the syncytiotrophoblast doesn't have a single nucleus. It has roughly 10 ...

The university's scientists have received a $28.5 million award from the Advanced Research Projects Agency for Health to develop a transplantable 3D-printed liver patch. The initiative ...

There are no 'safe use guarantees', but it's possible to reduce harm.

Critical Path Institute’s® Translational Therapeutics Accelerator today officially launched its 2026 global Request for Proposals for Bridging Research and Innovation in Drug Development Grants. These ...

Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company based in Taiwan committed to developing ...